Suboptimum use of FDA drug advisory committees

Lancet. 2006 Dec 23;368(9554):2210. doi: 10.1016/S0140-6736(06)69892-9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Advisory Committees / statistics & numerical data*
  • Advisory Committees / trends
  • Drug Approval
  • United States
  • United States Food and Drug Administration*